| Methylation associated inactivation of RASSF1A from region 3p21. 3 in lung, breast and ovarian tumours A Agathanggelou, S Honorio, DP Macartney, A Martinez, A Dallol, ... Oncogene 20 (12), 1509-1518, 2001 | 557 | 2001 |
| Role of the Ras-association domain family 1 tumor suppressor gene in human cancers A Agathanggelou, WN Cooper, F Latif Cancer research 65 (9), 3497-3508, 2005 | 541 | 2005 |
| Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid … O Goodyear, A Agathanggelou, I Novitzky-Basso, S Siddique, ... Blood, The Journal of the American Society of Hematology 116 (11), 1908-1918, 2010 | 372 | 2010 |
| CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions M Zimmermann, O Murina, MAM Reijns, A Agathanggelou, R Challis, ... Nature 559 (7713), 285-289, 2018 | 343 | 2018 |
| Epstein–Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV‐infected cells G Niedobitek, A Agathanggelou, H Herbst, L Whitehead, DH Wright, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997 | 301 | 1997 |
| ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells M Kwok, N Davies, A Agathanggelou, E Smith, C Oldreive, E Petermann, ... Blood, The Journal of the American Society of Hematology 127 (5), 582-595, 2016 | 275 | 2016 |
| Epigenetic inactivation of the RASSF1A 3p21. 3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma C Morrissey, A Martinez, M Zatyka, A Agathanggelou, S Honorio, D Astuti, ... Cancer research 61 (19), 7277-7281, 2001 | 270 | 2001 |
| Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease H Herbst, HD Foss, J Samol, I Araujo, H Klotzbach, H Krause, ... | 247 | 1996 |
| RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics A Dallol, A Agathanggelou, SL Fenton, J Ahmed-Choudhury, L Hesson, ... Cancer research 64 (12), 4112-4116, 2004 | 211 | 2004 |
| Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand A Hirano, DL Longo, DD Taub, DK Ferris, LS Young, AG Eliopoulos, ... Blood, The Journal of the American Society of Hematology 93 (9), 2999-3007, 1999 | 186 | 1999 |
| Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma G Niedobitek, A Agathanggelou, M Rowe, EL Jones, DB Jones, ... | 180 | 1995 |
| RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours D Astuti, A Agathanggelou, S Honorio, A Dallol, T Martinsson, P Kogner, ... Oncogene 20 (51), 7573-7577, 2001 | 172 | 2001 |
| Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients S Honorio, A Agathanggelou, M Schuermann, W Pankow, P Viacava, ... Oncogene 22 (1), 147-150, 2003 | 168 | 2003 |
| Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction … A Agathanggelou, G Niedobitek, R Chen, J Nicholls, W Yin, LS Young The American journal of pathology 147 (4), 1152, 1995 | 167 | 1995 |
| The association of squamous cell carcinomas of the nasopharynx with Epstein–Barr virus shows geographical variation reminiscent of Burkitt's lymphoma JM Nicholls, A Agathanggelou, K Fung, Z Xiangguo, G Niedobitek The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997 | 152 | 1997 |
| Epigenetic inactivation of the candidate 3p21. 3 suppressor gene BLU in human cancers A Agathanggelou, A Dallol, S Zöchbauer-Müller, C Morrissey, S Honorio, ... Oncogene 22 (10), 1580-1588, 2003 | 142 | 2003 |
| Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21. 3 in head and neck squamous cell carcinoma RP Hogg, S Honorio, A Martinez, A Agathanggelou, A Dallol, P Fullwood, ... European Journal of Cancer 38 (12), 1585-1592, 2002 | 141 | 2002 |
| Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer … A Agathanggelou, I Bièche, J Ahmed-Choudhury, B Nicke, R Dammann, ... Cancer Research 63 (17), 5344-5351, 2003 | 140 | 2003 |
| Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell … S Honorio, A Agathanggelou, N Wernert, M Rothe, ER Maher, F Latif Oncogene 22 (3), 461-466, 2003 | 134 | 2003 |
| Involvement of the RASSF1A tumor suppressor gene in controlling cell migration A Dallol, A Agathanggelou, S Tommasi, GP Pfeifer, ER Maher, F Latif Cancer research 65 (17), 7653-7659, 2005 | 119 | 2005 |
